title: ISTH 2015 Congress.
authors.forename: Lan-Lan
authors.initials: LL
authors.lastname: Smith
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D001182:Arthroscopy / Q000009:adverse effects; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D000069604:Dabigatran / Q000008:administration & dosage / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D000069552:Rivaroxaban / Q000627:therapeutic use; D061905:Single-Domain Antibodies / Q000627:therapeutic use; D054556:Venous Thromboembolism / Q000517:prevention & control*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D061905:Single-Domain Antibodies; C577506:recombinant factor VIII N8; C585343:caplacizumab; C078147:F8 protein, human; D005169:Factor VIII; C000594745:idarucizumab; D000069552:Rivaroxaban; D000069604:Dabigatran